SCHEMBL22978784

SCHEMBL22978784

NC(=O)OC1CCCN(CF)C1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
BCHE P06276 3/20 0.39
MAOB P27338 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ATM Q13315 1/20 0.39
DPP4 P27487 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
KDM4E B2RXH2 1/20 0.37
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3688386 0.83 CYP3A4 (0.56) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL3688385 0.83 CYP3A4 (0.56) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL29042805 0.82 CHRNB2 (0.41) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL3696868 0.81 BCHE (0.48) CYP3A4CYP1A2CYP2D6BCHESMN1; SMN2
SCHEMBL22978800 0.81 CYP3A4 (0.39) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL3687879 0.81 BCHE (0.48) CYP3A4CYP1A2CYP2D6BCHESMN1; SMN2
SCHEMBL3694790 0.80 CYP3A4 (0.43) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL3756225 0.80 CYP3A4 (0.38) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL3757483 0.80 CYP3A4 (0.38) CYP3A4CYP1A2CYP2D6BCHEMAOB
SCHEMBL3694792 0.80 CYP3A4 (0.43) CYP3A4CYP1A2CYP2D6BCHEMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026803-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-02-18 WO disclosed